Research Scientist (Biologics)

We are an ambitious cyanobacterial biologics platform company seeking an outstanding candidate for the role of Research Scientist. As a highly-motivated individual, you will specialise in design, development, delivery and testing of novel cyanobacterial biologics, including monoclonal antibodies, VLP vaccines, & therapeutic proteins. You will tackle a range of challenges as an integral part of the team, and demonstrate a high degree of flexibility, creativity, and initiative. You will have team leadership experience, be adaptable, work well collaboratively, and be able to thrive in a start-up environment.

• Development of genetic designs in collaboration with CTO
• Creation & execution of genetic design strategies, including:
• Design of genetic biologic expression components
• Design of plasmids; Management of build & verification process
• Management of cyanobacteria strain pipeline, including sequence verification
• Working with downstream processing lead to coordinate analysis pipeline
• Support in vitro & preclinical evaluation of biologics, in collaboration with R&D team & CTO
• Updating CTO and Executive on status and timelines for biologics & preclinical material preparation
• Management of lab resources; overseeing smooth functioning of the strain engineering pipeline
• Managing preclinical material production, in collaboration preclinical testing collaborators

• Ph.D. in Bioengineering, Synthetic Biology, Immunology, Microbiology, or closely-related area,
• Competent in microorganism design; hands-on experience with the latest genetic engineering tools, including multi-fragment DNA assembly, cloning, and prokaryotic transformation essential

• Industrial/postdoctoral lab experience within biotechnology, immunology, vaccine development or therapeutics
• Experience engineering cyanobacteria
• VLP, mAb and therapeutic protein expression, purification, delivery or testing
• ELISA-based testing & in vitro/in vivo therapeutic characterisation
• Experience with mammalian cell culture & mAb expression
• Conducted preclinical development studies of mAbs, vaccines or therapeutic proteins
• Experience using computational tools for protein design

Bondi Bio is an Australian biotechnology company developing a novel platform for the biomanufacture and delivery of biologics using bioengineered cyanobacteria. The platform offers a cost-effective and rapidly-scalable solution to produce monoclonal antibodies, vaccines, and therapeutic proteins. Bondi's food-grade cyanobacteria has the potential for distributed biomanufacturing and point-of-care needle-free delivery. Bondi is working to bring next-generation biologics to market.